Microvesicles from quiescent and TGF-β1 stimulated hepatic stellate cells: Divergent impact on hepatic vascular injury
Jianlong Xie, Zhirong Ye, Xiaobing Xu, Anzhi Chang, Ziyi Yang, Qin Wu, Qunwen Pan, Yan Wang, Yanyu Chen, Xiaotang Ma, Huilai Miao, Palash Mandal, Palash Mandal, Palash Mandal
TL;DR
This study shows that microvesicles from resting liver cells protect blood vessels, while those from TGF-β1-stimulated cells worsen liver injury.
Contribution
The study reveals divergent effects of microvesicles from quiescent versus TGF-β1-stimulated hepatic stellate cells on vascular injury.
Findings
Quiescent HSC-MVs protect endothelial cells and reduce liver injury in rats.
TGF-β1-stimulated HSC-MVs increase cytotoxicity and worsen liver damage.
Effects are mediated through pathways like PI3K/AKT/VEGF and MEK/ERK/eNOS.
Abstract
This study evaluated the effect of microvesicles(MVs) from quiescent and TGF-β1 stimulated hepatic stellate cells (HSC-MVs, TGF-β1HSC-MVs) on H2O2-induced human umbilical vein endothelial cells (HUVECs) injury and CCl4-induced rat hepatic vascular injury. HUVECs were exposed to hydrogen peroxide (H2O2) to establish a model for vascular endothelial cell injury. HSC-MVs or TGF-β1HSC-MVs were co-cultured with H2O2-treated HUVECs, respectively. Indicators including cell survival rate, apoptosis rate, oxidative stress, migration, invasion, and angiogenesis were measured. Simultaneously, the expression of proteins such as PI3K, AKT, MEK1+MEK2, ERK1+ERK2, VEGF, eNOS, and CXCR4 was assessed, along with activated caspase-3. SD rats were intraperitoneally injected with CCl4 twice a week for 10 weeks to induce liver injury models. HSC-MVs or TGF-β1HSC-MVs were injected into the tail vein of rats.…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Fig 1
Fig 2
Fig 3
Fig 4
Fig 5
Fig 6
Fig 7- —http://dx.doi.org/10.13039/501100001809National Natural Science Foundation of China
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsExtracellular vesicles in disease · Liver Disease and Transplantation · Organ Transplantation Techniques and Outcomes
Introduction
Severe, acute, and persistent chronic liver injury may lead to liver fibrosis, potentially culminating in liver cancer or failure [1]. The microenvironmental alterations during liver injury repair are complex, with sinusoidal endothelial cells and non-parenchymal cells contributing to liver fibrosis during the repair process [2]. In normal liver, HSCs maintain a non-proliferative, quiescent phenotype. Following liver injury or culturein vitro, HSCs become activated, trans-differentiating from vitamin-A-storing cells to myofibro-blasts, which are proliferative, contractile, inflammatory and chemotactic. They also synthesize and secrete large amounts of extracellular matrix (ECM). The excessive accumulation of ECM leads to liver structural remodeling and fibrosis formation [3].Studies have shown that Hepatic stellate cells and endothelial cells maintain hematopoietic stem cells during liver development through the production of stem cell factor (SCF) [4]. Moreover, HSCs secrete matrix metalloproteinases (MMPs), different MMPs and their inhibitors have been explored in preclinical studies for the treatment of liver diseases by degrading the most abundant fibrotic extracellular matrix (ECM) protein col-I, thereby facilitating liver damage repair and regeneration [5]. Recent studies, including those in this project, have demonstrated that HSCs release MVs and non-cellular components to regulate the functions of liver cells and vascular endothelial cells, highlighting the pivotal role of HSC-derived MVs as communication carriers in the regulation of hepatic cell injury repair, which has garnered significant research attention [6, 7].
MVs are a type of extracellular vesicle formed by budding and are currently recognized as new communication carriers between cells [8]. MVs contain various signaling molecules such as proteins and nucleic acids, released upon binding to recipient cells, playing crucial roles in regulating cell morphology and function [9]. The composition of MVs is determined by the state of the producing cells and closely correlates with their functions [10]. Our previous study demonstrated that MVs released by HSCs in their quiescent state (HSC-MVs) can inhibit caspase-3 protein expression and significantly reduce AST, ALT, and LDH levels, thereby preserving liver cell function in acetaminophen(APAP)/H_2_O_2_-injured liver cells [7]. However, MVs generated by TGF-β1 activated HSCs (TGF-β1HSC-MVs) led to a dose-dependent down-regulation of the PI3K/Akt and Erk1/2 pathways, along with the promotion of caspase-3 expression, ultimately leading to hepatocyte apoptosis when damaged hepatocytes were co-cultured with ^TGF-β1^HSC-MVs [11]. These findings suggest that HSC-MVs can protect damaged hepatocytes, while TGF-β1HSC-MVs can promote liver cell injury.
HSCs, originally identified by von Kupffer in 1876, are localized in the subendothelial space of Disse, interposed between liver sinusoidal endothelial cells (LSECs) and hepatocytes; they represent ~10% of all resident liver cells [12]. There is a close relationship between LSECs and HSCs. LSECs release vascular endothelial growth factor (VEGF), inducing proliferation of HSCs and angiogenesis after liver parenchymal injury. VEGF promotes fiber formation and may also be necessary for liver tissue repair and fibrosis resolution [3]. HSC-MVs protects against liver cell damage, while TGF- β 1HSC-MVs exacerbate liver cell damage. What is their impact on liver sinusoidal endothelial cells? Further clarification is still needed. This article uses H_2_O_2_ to induce HUVECs injury and CCl_4_ to induce rat liver injury, further investigating the effects of HSC-MVs and TGF-β1HSC-MVs on injured endothelial cells and intrahepatic vessels.
Materials and methods
Cell lines and culture conditions
LX-2 cells (P4) were obtained from Jennio Biological Technology (JBT, Guangdong, China) and used for MVs preparation. HUVECs (P4) were sourced from the American Type Culture Collection (ATCC, Manassas, VA, USA). P5 to P10 cells were used for experiments.
LX-2 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco, Cat#: 8120365), while HUVECs were cultured in an F-12K basal medium (Gibco, Cat#: 11330032) supplemented with 10% fetal bovine serum (FBS, Gibco, USA) and 1% penicillin-streptomycin (Gibco). The culture conditions were maintained in a humid incubator with temperature and CO_2_ levels set at 37°C and 5%, respectively.
Preparation and analysis of HSC-MVs and TGF-β1HSC-MVs
HSC-MVs and TGF-β1HSC-MVs were generated from LX-2 cells treated with LX-2 and TGF-β1(10ng/ml), respectively. Upon reaching 80% confluence, LX-2 cells were subjected to serum-free medium for 72 h, and MVs were collected through differential centrifugation [13]. The morphology, size, and quantity of MVs were examined using transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA).
Cellular model of vascular injury
HUVECs (5×10^3^ cells/100 μL) were seeded in a 96-well culture plate and incubated until reaching 80% confluence. Subsequently, the cells were treated with H_2_O_2_ at concentrations ranging from 300 to 700 μM for 20 h. Cell morphology was observed under a microscope and cell viability was assessed using the CCK-8 assay (Cat # CK04; Dojindo, Japan). The IC50 value of H_2_O_2_ on HUVECs was determined to establish an in vitro model of endothelial cell injury [14].
Cell proliferation detection
The HUVECs were cultured according to the aforementioned procedures. When cell confluence reached 80%, 2×10^8^/mL HSC-MVs and TGF-β1HSC-MVs were added. Meanwhile, 600μM H_2_O_2_ was introduced, and co-culturing continued for an additional 24h. Cell proliferation was assessed using the CCK-8 assay.
Lactate dehydrogenase assay
Following the experimental procedure outlined for HUVECs, we measured lactate dehydrogenase (LDH) release using an LDH Activity Assay Kit (Dojindo, Japan, Catalog #: CK12), following the manufacturer’s instructions.
Cell apoptosis detection
The Annexin V-PE/7AAD Apoptosis Detection Kit (BD Biosciences, USA, Catalog #: 559763) was used to analyze apoptosis in treated HUVECs, following the manufacturer’s instructions. After co-culture, HUVECs were fixed, stained with Annexin V-PE and 7-AAD solution, and subjected to flow cytometry using a BD FACSCalibur (USA).
Reactive oxygen species (ROS) production analysis
Intracellular ROS levels were quantified using DCFH-DA (Cat #: CA1410; Solarbio, China), following the manufacturer’s guidelines. After the aforementioned treatments, HUVECs were exposed to the DCFH-DA solution for 20 min at 37°C. The fluorescence intensity of ROS within the cells was observed using a fluorescence microscope. Five randomly selected fields were observed, and the cell count, and average were determined.
Migration assays
Cell migration assays were conducted using transwell chambers (Falcon, Corning, USA, Cat#: 354234) equipped with a polycarbonate membrane. In the transwell migration assay, 7×10^4^ HUVEC cells (200μL) were seeded in the upper chambers in 2.5% FBS medium. The upper chambers were treated with MVs (HSC-MVs or TGF-β1HSC-MVs) and 600 μM H_2_O_2_, while the lower chambers contained 20% FBS. After 16 h of incubation, cells in the upper chambers were removed, and cells in the lower chambers were stained with crystal violet (Beyotime, China, Cat#: C0121) at 25°C for 1 min. The cells were then observed and counted under a microscope. Cells from five randomly selected fields were counted and averaged.
Tube formation assay
After thawing, the basement membrane matrix (Matrigel, Corning, USA, Cat#:354234) was dissolved at 4°C and added to 48-well plates at a volume of 100μl per well. The plates were then incubated at 37°C for 1 h. Next, 2×10^4^ HUVECs were seeded in 200μl of serum-free endothelial cell medium and added to the Matrigel-coated wells. The control group was treated with medium alone, while the test group was treated with a mixture of MVs (HSC-MVs or TGF-β1HSC-MVs) and H_2_O_2_. Total tube branching length, segments, and junctions were calculated using the ImageJ software.
Western blot
Proteins from cells were extracted using a lysis buffer. Protein lysates were separated using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene fluoride (PVDF) membranes. The membranes were blocked for 1 h with 5% BSA and then incubated with primary antibodies against Cleaved caspase-3 (1:500, Cat#: ab2302), VEGF (1:1000, Cat#: ab32152), eNOS (1:1000, Cat#:ab199956), CXCR4 (1:1000, Cat#: ab181020), PI3K (1:2000, Cat#: ab140307), P-PI3K (1:1000, Cat#: ab182651), Akt (1:500, Cat#: ab8805), P-Akt (1:5000, Cat#: ab81283), Erk1/2 (1:10000, Cat#: ab184699), P-Erk1/2 (1:1000, Cat#: ab201015), GAPDH (1:5000, Cat#: ab8245), Tubulin (1:2000, Cat#: ab7291), and β-Actin (1:1000, Cat#: ab8226) (all from Abcam, USA) at 4°C overnight. After washing thrice for 30 min each with Tris-buffered saline Tween-20 (TBST), immunoreactivity was visualized using an ECL solution (Amersham, Sweden). Finally, grayscale maps of the bands were analyzed using ImageJ software.
In vivo rat model of liver injury
Forty adult male Sprague-Dawley (SD) rats of SPF grade, weighing 180 and 220 g, were obtained from the Experimental Animal Center of Guangdong. The rats were acclimated in the Laboratory Animal Center of Guangdong Medical University for one week under controlled environmental conditions (23–25°C, 12-h dark/light cycle) before commencing the experiments. All the animals received appropriate care during the study with free access to food and water. This study received approval from the Animal Ethics Committee of Guangdong Medical University (NO. GDY1902010), adhering to the committee’s guidelines for the care and use of laboratory animals.
A chronic liver injury model was established in rats by administering intraperitoneal injections of CCl_4_ (50%, 1 ml/kg) twice weekly for 10 weeks [15]. The rats were randomly divided into four groups, each comprising 10 rats: (1) Control group: Rats received intraperitoneal injections of olive oil twice a week for 10 weeks; (2) CCl_4_ group: Rats were intraperitoneally injected with CCl_4_ twice a week for 10 weeks; (3) HSC-MVs-CCl_4_ group: Rats received intravenous injections of stationary HSC-MVs at a concentration of 200μl (2×10^8^/ml) via the tail vein and intraperitoneal injections of CCl_4_ twice a week for 10 weeks; (4) TGF-β1HSC-MVs-CCl_4_ group: Rats were intravenously injected with TGF-β1HSC-MVs at a concentration of 200μl (2×10^8^/ml) via the tail vein and intraperitoneally injected with CCl_4_ twice a week for 10 weeks.
Upon completion of the experiment, rats were subjected to cardiac blood collection using syringes under 2.5% isoflurane general anesthesia. Blood samples were sent to the Laboratory Department of Guangdong Medical University Affiliated Hospital for ALT and AST measurements. Under deep anesthesia, the rats were euthanized by cervical dislocation. Liver tissue was collected through an abdominal incision, with a portion fixed in 4% paraformaldehyde for 24 h, subsequently embedded in paraffin for measurement of histomorphology, immunohistochemistry and immunofluorescent staining. Another portion was rapidly frozen in liquid nitrogen and stored at -80°C for measurement of Western blot.
Histological examination
The liver tissue samples were subjected to hematoxylin and eosin (H&E) staining to evaluate their morphological features. Masson’s trichrome staining was performed to assess the degree of collagen damage in hepatic vessels.
Immunohistochemistry
Paraffin-embedded liver tissues were sectioned into 4–6 mm pieces, followed by deparaffinization and sequential dehydration in ethanol. The sections underwent a 3-min boiling step and were immersed in EDTA-Tris (pH 9.0) for antigen retrieval. Subsequently, they were treated with hydrogen peroxide for 30 min to inactivate endogenous peroxidases. The sections were then subjected to an overnight incubation at 4°C with primary antibodies, including those against CD31 (1:2000, Abcam, USA, Cat#: ab182981), CD34 (1:200, Abclonal, China, Cat#: A0761), and αSMA (1:2500, Abcam, USA, Cat#: ab124964). Appropriate biotinylated secondary antibodies (goat anti-rabbit IgG and goat anti-mouse IgG; Abcam, Cambridge, USA) were added to the sections, which were then incubated for 30 min at room temperature(20~25°C). The sections were stained with diaminobenzidine (DAB) and counterstained with hematoxylin; the positive areas appeared brownish yellow. Immunohistochemistry results were analyzed using Image-Pro Plus software.
Immunofluorescent staining
The samples were incubated with periodate-lysine-paraformaldehyde fixative at room temperature for 3 h. After cryoprotection with 30% sucrose/0.1M phosphate buffer (pH 7.2), approximately 20-μm thick cryostat sections were cut, and nonspecific staining was blocked by incubating the sections with 1% bovine serum albumin/PBS for 1 h. The sections were then incubated at room temperature for 24 h with primary antibodies, including Anti-CD31 (1:200, Abclonal, China, Cat# A2104), Anti-CD34 (1:200, Abclonal, China, Cat# A0761). Subsequently, the sections were washed three times with wash buffer (Beyotime) and incubated with a mixture of secondary antibodies at room temperature for 1 h. Negative control staining was performed by replacing the primary antibodies with control IgG for each immunized animal. The secondary antibodies used were Alexa Fluor 488 (Abcam, USA, Cat#: ab150077) conjugated donkey anti-rabbit and rat IgG, purchased from Abcam. Sections were observed under a confocal scanning laser microscope (Leica, TCS SP5II, Germany) after double labeling. For each animal, eight randomly chosen low-power optical fields were selected, and the number of positive cells was counted for each single channel and merged channel for each marker. Five animals were analyzed for each marker.
Statistical analysis
Statistical analyses were performed using SPSS 25.0 software. Experimental results are expressed as mean ± standard deviation ( ± SD). Comparisons among multiple groups were conducted using one-way ANOVA, preceded by a homogeneity of variance test. Post-hoc comparisons were performed using either the LSD or Tamhane’s test. Statistical significance was set at P<0.05.
Results
H2O2 induced HUVECs injury model
H_2_O_2_ damaged HUVECs in a concentration-dependent manner. Fig 1A shows the morphological changes in HUVECs treated with different concentrations of H_2_O_2_. In the 0μM group, a single cell appeared as a short spindle or polygon with a plump morphology, and the confluent cell monolayer exhibited a cobblestone appearance. In the H_2_O_2_ group, cells displayed varying degrees of shrinkage, rounding, and shedding. H_2_O_2_ reduced HUVECs viability in a concentration-dependent manner. When HUVECs were exposed to varying concentrations of H_2_O_2_ (0, 300, 400, 500, 600, and 700μM), the cellular viability rate was negatively correlated with the concentration of H_2_O_2_ (r = 0.92, P<0.01; Fig 1B). Using GraphPad software, the half maximal inhibitory concentration (IC_50_) of H_2_O_2_ required to impair HUVECs was estimated to be 623.6μM (Fig 1C). Consequently, H_2_O_2_ at a concentration of 600μM was implemented in the subsequent experiments.
*The influence of different concentrations of H2O2 on the morphology and the viability rates of HUVECs and the characterization of HSC-MVs and TGF-β1HSC-MVs.A. The morphology of HUVECs under an optical microscope, scale bar:100μm; B. The viability rates; C. IC50 value of H2O2 on HUVECs viability rate. mean土SD, n = 6. *P<0.05, *P<0.01, vs 0μM group. IC50: The half maximal inhibitory concentration, represents the concentration of H2O2 that is required for 50% inhibition of HUVECs. D and E. The size and morphology of HSC-MVs and TGF-β1HSC-MVs were detected using TEM, scale bar:100nm and 500nm; F and G. Particle size distribution in purified HSC-MVs and TGF-β1HSC-MVs were determined by NTA.
Characteristics of MVs
Transmission electron microscopy (TEM) analysis revealed that the MVs had a round shape, intact membranes, and were present as single or multiple aggregates. The particle size ranged from 150 to 500 nm, consistent with the typical range of 100–1000 nm of MVs (Fig 1D and 1E).
The results of nanoparticle tracking analysis (NTA) indicated that HSC-MVs and TGF-β1HSC-MVs had sizes ranging from 100 to 600 nm, with concentrations around 2×10^8^ /ml of cell culture medium (Fig 1F and 1G). These findings confirmed that the HSC-MVs and TGF-β1HSC-MVs isolated from the HSCs culture medium were indeed MVs.
HSC-MVs increased viability, reduced cytotoxicity, and inhibited apoptosis, while TGF-β1HSC-MVs decreased viability, enhanced cytotoxicity, and apoptosis in the H2O2 induced HUVECs injury model
Using the CCK8 proliferation assay, the results demonstrated that after 20 h of exposure to 600μM H_2_O_2_, compared with that of the control group, the HUVECs viability rate decreased by 37% (P<0.01). HSC-MVs significantly improved the proliferation ability of H_2_O_2_-injuried HUVECs; the viability rate increased by 13% compared with that of the H_2_O_2_ group (P<0.01). Conversely, TGF-β1HSC-MVs exacerbated the cellular injury effect of H_2_O_2_, with an 8% reduction in HUVECs viability rate compared with that of H_2_O_2_ group (P<0.01) (Fig 2A).
*Effects of HSC-MVs and TGF-β1HSC-MVs on H2O2 induced HUVECs injury.A. Viability, (n = 4); B. Cytotoxicity, (n = 4); C. Statistical chart of apoptosis (n = 3); D. Flow cytometry graph of apoptosis; E and F. Cleaved Caspase-3 protein expression, (n = 3); mean ± SD. *p<0.05, *p<0.01, vs control group; #p<0.05, ##p<0.01, vs H2O2 group.
The lactate dehydrogenase (LDH) release assay and annexin V-PE/7-AAD analysis indicated that H_2_O_2_ exposure increased the cytotoxicity and apoptosis of HUVECs (vs. control group; P<0.01; Fig 2B and 2D). However, treatment with HSC-MVs significantly reduced the cytotoxicity and cell apoptosis rate (vs. the H_2_O_2_ group; P<0.01; Fig 2B and 2D). Conversely, treatment with TGF-β1HSC-MVs significantly increased the cytotoxicity and the cell apoptotic rate (vs. H_2_O_2_ group; P<0.01; Fig 2B and 2D). Additionally, western blot analysis showed that H_2_O_2_ promoted the expression of the apoptosis-related protein, Cleaved Caspase-3 (vs. control group; P<0.01). However, treatment with HSC-MVs inhibited the expression of Cleaved Caspase-3 compared with that in the H_2_O_2_ group (P<0.05). In contrast, treatment with TGF-β1HSC-MVs upregulated the protein expression of Cleaved Caspase-3 (vs. H_2_O_2_ group; P<0.01; Fig 2E and 2F).
Differential effects of HSC-MVs and TGF-β1HSC-MVs on oxidative stress, cell migration and angiogenesis in H2O2-induced HUVECs injury
In the H_2_O_2_ induced HUVECs injury model, HSC-MVs improved oxidative stress response, cell migration ability and angiogenesis, whereas the effects of ^TGF-β1^HSC-MVs were precisely the opposite.
H_2_O_2_ led to an elevation in ROS. DCFH-DA staining revealed that after 20h of exposure to 600μM H_2_O_2_, the number of ROS-positive cells in the H_2_O_2_ group increased by 4.4 times compared with that in the control group (p<0.01). Treatment with HSC-MVs significantly mitigated the elevated levels of ROS; the number of ROS-positive cells in the H_2_O_2_+HSC-MVs group decreased by 1.5 times compared with that in the H_2_O_2_ group (P<0.01). Conversely, treatment with TGF-β1HSC-MVs further increased the levels of ROS; the number of ROS-positive cells in the H_2_O_2_+TGF-β1HSC-MVs group increased by 1.2 times compared with that in the H_2_O_2_ group (P<0.01) (Fig 3A and 3D).
*The effects of HSC-MVs and TGF-β1HSC-MVs on oxidative stress, cell migration and angiogenesis in the H2O2 induced HUVECs injury model.A, D. Reactive oxygen species (ROS), using DCFH-DA staining. A, Image under fluorescence microscope; D, Statistical Chart of Fluorescent Cell Count (n = 4). B, E. The cellular migration ability, using transwell chambers and crystal violet stained. B, Optical Microscopic Image of Crystal Violet Staining; E, Statistical chart of the number of transmembrane migrating cells (n = 4). C, F, G, H Angiogenesis. C, Image of angiogenesis under light microscope. F, G, H, Statistical analysis of tube formation. The number of branch segments (Nb Segments) (F); the number of branch junctions (Nb Junctions) (G), and the number of total branching length (Tol. Branching Length) (H), (n = 4). The data were expressed as mean ± SD. *p<0.05, *p<0.01, vs control group; #p<0.05, ##p<0.01, vs H2O2 group.
Transwell migration assay and crystal violet staining revealed that H_2_O_2_ inhibited the migration of HUVECs; the cell migration rate in the H_2_O_2_ group was 76% lower than that in control group (p<0.01). HSC-MVs effectively improved cell migration, while ^TGF-β1^HSC-MVs further inhibited cell migration. Compared with that in the H_2_O_2_ group, the cell migration rate in the H_2_O_2_+ HSC-MVs group increased by 17%, while that in the H_2_O_2_+TGF-β1HSC-MVs group decreased by 14% (both P<0.01) (Fig 3B and 3E).
The in vitro angiogenesis experiment, also known as the endothelial tube formation assay, displayed morphological changes of cells incubated on the matrix gel for 24h (Fig 3C, 3F–3H). As shown in Fig 3C, the cells extend their protrusions, which come into contact with each other to form a capillary-like network structure. In the control group, the capillary-like network structure was clear, complete, and dense, while in the H_2_O_2_ group, the network structure was sparse and incomplete. In the H_2_O_2_+ HSC-MV group, the capillary-like network structure was similar to that in the control group. In the H_2_O_2_+TGF-β1HSC-MVs group, the capillary like network structure almost disappeared, with only fragments and scattered small branches visible. The in vitro angiogenic capacity of each group was evaluated by analyzing the number of branch segments, branch intersections, and the total branch length in the capillary-like network structure. As shown in Fig 3F–3H, the number of branch segments (Nb Segments) (F), branch intersections (Nb Junctions) (G), and the total branch length (Tol. Branching Length) (H) in the H_2_O_2_ group were lower than that in the control group, with decreases of 48%, 41%, and 33%, respectively, all P<0.01. The H_2_O_2_+HSC-MVs group exhibited an increase of 21%, 15%, and 14%, respectively, compared with the H_2_O_2_ group (all P<0.01). The H_2_O_2_+TGF- βHSC-MVs group showed a decrease of 15%, 15%, and 12% compared with the H_2_O_2_ group (all P<0.01) (Fig 3C and 3H).
HSC-MVs upregulated the expression of PI3K, AKT, MEK1/2, ERK1/2, and angiogenesis-associated proteins in the H2O2-induced HUVECs injury model. Conversely, TGF-β1HSC-MVs inhibited the expression of these proteins
PI3K, AKT, MEK, ERK, etc. are important signaling molecules that regulate cell proliferation, differentiation, apoptosis, migration, and angiogenesis. The Western blot method was used to detect the protein expression of these signal molecules, and the results showed that no significant difference was noted in the total protein expression of PI3K or AKT between the control group and the H_2_O_2_ group, or H_2_O_2_+HSC-MVs group, or H_2_O_2_+TGF-β1HSC-MVs group. However, phosphorylated PI3K and AKT showed a downregulation of protein expression levels in H_2_O_2_ treated groups, all lower than the control group by 29% and 30%, p<0.01, compared with those in the control group. Static HSC-MVs upregulated the expression of phosphorylated PI3K or AKT proteins; the H_2_O_2_+HSC-MVs group was upregulated by 12% and 13% compared with the H_2_O_2_ group (p<0.01). TGF-β1 activated HSC-MVs further downregulated the expression of phosphorylated PI3K or AKT protein; H_2_O_2_+TGF-β1HSC-MVs group showed a 10% and 19% downregulation compared with the H_2_O_2_ group (p<0.05) (Fig 4A and 4B).
*The effects of static HSC-MVs and TGF-β1 stimulated HSC-MVs on the expression of signal proteins related to cell proliferation, apoptosis, oxidative stress, angiogenesis, etc.in the H2O2 induced HUVECs injury model. A to B, p-PI3K, PI3K, p-AKT, AKT; C to D, p-MEK, MEK, p-ERT, ERT; E to F, VEGF, eNOS, CXCR4. A, C and E are the images displayed by western blotting; B, D and F are statistical charts. The expression levels were normalized with GAPDH or Tubulin. All experiments have been performed in triplicate and data were expressed as mean ± SD. *p<0.05, *p<0.01, vs. control group; #p<0.05, ##p<0.01, vs H2O2 group. H2O2 concentrations:600μM, HSC-MVs and TGF-β1HSC-MVs concentrations: 2×108 /ml.
Similar to PI3K and AKT, there were no significant differences in the total protein expression levels of MEK1/2 or ERK1/2 between the control group and the H_2_O_2_ groups. However, H_2_O_2_ leads to the downregulation of phosphorylated MEK1/2 and ERK1/2 proteins. Compared with the control group, the H_2_O_2_ group downregulated by 27% and 30% (p<0.01). Static HSC-MVs can reverse the downregulation of phosphorylated MEK1/2 and ERK1/2 protein expression caused by H_2_O_2_, while ^TGFβ1^HSC-MVs further exacerbate the downregulation of phosphorylated MEK1/2 and ERK1/2 protein expression. Compared with those in the H_2_O_2_ group, the protein expressions MEK1/2 and ERK1/2 were upregulated by 13% and 16% in the H_2_O_2_+HSC-MVs group (p<0.05); the H_2_O_2_+TGF-β1HSC-MVs group downregulated by 16% and 14% (p<0.05) (Fig 4C and 4D).
Signaling proteins related to angiogenesis, such as VEGF, eNOS, and CXCR4, react similarly to these proteins. H_2_O_2_ stimulation leads to the downregulation of VEGF, eNOS, and CXCR4 protein expression HSC-MVs can reverse the downregulation of protein expression, while TGF-β1HSC-MVs exacerbate the downregulation of protein expression. As shown in Fig 4E and 4F, the level of protein expressions of VEGF, eNOS, and CXCR4 in all groups treated with H_2_O_2_ were lower than those in the control group (all p<0.01). The expression of these three proteins in the H_2_O_2_+HSC-MVs group was higher than that in the H_2_O_2_ group (p<0.05). The expression of three proteins in the H_2_O_2_+^TGF-β1^HSC-MVs group was further downregulated, compared with that in the H_2_O_2_ group (p<0.05 or p<0.01).
Effects of HSC-MVs and TGF-β1HSC-MVs on CCl4-induced rat liver injury
Rats treated with CCl_4_ exhibited a substantial increase in serum ALT and AST levels, surpassing those in the control group by 20 and 30 times, respectively (P<0.01). The combination of HSC-MVs with CCl_4_ resulted in a notable reduction in serum ALT and AST levels. Specifically, the HSC-MVs+CCl_4_ group demonstrated a mere 1.1 and 1.5 times increase compared with the control group but exhibited a significant 30% and 40% decrease, respectively, in contrast to the CCl_4_ -alone group (P<0.01). Conversely, co-administration of TGF-β1HSC-MVs with CCl_4_ further increased serum ALT and AST levels. The TGF-β1HSC-MVs+CCl_4_ group displayed a 3-fold and 4.5-fold increase compared with the control group, and a 1-fold and 1.3-fold increase compared with the CCl_4_- alone group (all P<0.01) (Fig 5A and 5B).
*The effects of static HSC-MVs and TGF-β1 stimulated HSC-MVs on the leakage of AST and ALT and the extent of liver fibrosis in CCl4-treated rats.A B. The levels of ALT and AST in rat serum, **p<0.01, p<0.05 vs. control group; ##p<0.01, #p<0.05 vs. CCl4 group (n = 10). C. H&E staining for liver sections, scale bars: 200μm and 50μm. D. Masson trichrome staining for liver sections, scale bars: 200μm and 100μm.
Histopathological examination of liver tissues revealed hepatocellular fatty degeneration and inflammatory cell infiltration. The combination of HSC-MVs and CCl_4_ (HSC-MVs+CCl_4_ group) mitigated the formation of liver fat vacuoles and the infiltration of inflammatory cells. In contrast, TGF-β1HSC-MVs (TGF-β1HSC-MVs+CCl_4_ group) exacerbated the formation of hepatic fat vacuoles and the infiltration of inflammatory cells (Fig 5C). Masson’s trichrome staining was used to assess the formation of fibrous tissue, fibrous septa, and perivascular collagen fibers in liver tissue. The CCl_4_-alone group exhibited increased hyperplasia of fibrous tissue and the formation of fibrous septa and perivascular collagen fibers. Conversely, administration of HSC-MVs resulted in a significant decrease in the amount of fibrotic tissue and collagen fibers. However, treatment with TGF-β1HSC-MVs enhanced the levels of fibrosis tissue and collagen fibers (Fig 5D).
Effects of HSC-MVs and TGF-β1HSC-MVs on CD31, CD34 and α-SMA expression in CCl4-treated rats analyzed through immunohistochemistry staining and immunofluorescence staining
The results of immunohistochemistry and immunofluorescence showed minimal or negative expression of CD31 and CD34 in the control group, contrasting with a significant increase observed in the CCl_4_ group. Co-treatment with HSC-MVs and CCl_4_ led to a reduction in CD31 and CD34 expression, while TGF-β1HSC-MVs enhanced their expression. The integrated optical density (IOD) values, measured using Image-Pro Plus software, immunohistochemical results showed that the CD31 and CD34 IOD values in the CCl_4_ group were 8 times and 6.5 times higher than those in the control group, respectively (both P<0.01). In the HSC-MVs+CCl_4_ group, these values decreased by 57% and 52% compared with the CCl_4_ group (both P<0.01); whereas in the TGF-β1HSC-MVs+CCl_4_ group, they increased by 89% and 96% compared with those of the CCl_4_ group (both P<0.01) (Fig 6A, 6B, 6E and 6F). Immunofluorescence results showed that the CD31 and CD34 IOD values in the CCl_4_ group were 5-fold and 5.5-fold elevation, compared with the control group (both P<0.01). In the HSC-MVs+CCl_4_ group decreased by approximately 48% and 56% compared with that in the CCl_4_ group (both P<0.01). In contrast, the TGF-β1HSC-MVs+CCl_4_ group exhibited an approximately 64% and 50% increase, compared with the CCl4 group (both P<0.01) (Fig 6C, 6D, 6G and 6H).
*The effects of static HSC-MVs and TGF-β1 stimulated HSC-MVs on the expression of CD31 and CD34 in CCl4-treated rats using immunohistochemical and immunofluorescence staining method.A and B. Immunohistochemical images. A. CD31, scale bars: 200μm and 100μm. B. CD34, scale bars:100μm and 50μm. C and D. Photo under a fluorescence microscope. Blue: Hoechst33342 staining, showed all cells. Red: Positive expression of proteins. C. CD31, scale bars: 50μm. D. CD34, scale bars: 50μm. E to F. Statistical graph of the integrated optical density (IOD), IOD values were measured using Image-Pro Plus software. **p<0.01, p<0.05 vs. control group. ##p<0.01, #p<0.05 vs. CCl4 group. Each group consists of five rats, with three slices taken from each rat, and each slide took five pictures.
Furthermore, the impact of HSC-MVs and TGF-β1HSC-MVs on α-smooth muscle action(α-SMA) expression was examined through immunohistochemistry. Fig 7A and 7B illustrates that CCl_4_ induced α-SMA expression, resulting in a significant increase compared with that in the control group. Co-treatment with HSC-MVs and CCl_4_ attenuated α-SMA expression, while co-treatment with TGF-β1HSC-MVs and CCl_4_ enhanced α-SMA expression. The IOD value measurement for α-SMA expression demonstrated that in the CCl_4_ group, the IOD value was 5.3 times higher than that of the control group. The HSC+CCl_4_ group exhibited a 48% decrease compared with the CCl_4_ group, while the TGF-β1HSC-MVs+CCl_4_ group increased by 1.3 times compared with the CCl_4_ group (all P<0.01).
*The effects of static HSC-MVs and TGF-β1 stimulated HSC-MVs on the expression of α-SMA in CCl4 induced rat liver injury using immunohistochemical method.A. Immunohistochemical images of α-SMA, scale bars: 200μm and 50μm. B. Statistical graph of the integrated optical density (IOD), IOD values were measured using Image-Pro Plus software. **p<0.01, p<0.05 vs. control group. ##p<0.01, #p<0.05 vs. CCl4 group. Each group consists of five rats, with three slices taken from each rat, and each slide took five pictures.
Discussion
Extracellular vesicles (EV) consist of a heterogeneous population of nanosized particles enclosed in a lipid bilayer without a functional nucleus [16]. Depending on experimental conditions or the cellular release site (basolateral or apical face), the same cell type may secrete EVs with distinct cargo. EVs are classified into three discrete categories based on size and origin: exosomes, microvesicles, and apoptotic bodies [17]. Microvesicles, produced through outward budding and fission of the plasma membrane, are larger, ranging from 100 to 1000 nm [18]. In this study, nanoparticles were obtained using gradient centrifugation, with sizes ranging from 150 to 500nm (unstimulated HSC) or 100 to 600nm (TGF-β1 stimulated HSC). These particles exhibited a rounded shape and intact membranes, appearing as single or multiple aggregates under a transmission microscope. These results align with the reported surface characteristics of microvesicles in the literature [19].
To investigate the impact of HSC-MVs on vascular endothelial cell function, a cell model of HUVECs injury induced by H_2_O_2_ was employed. The results demonstrated concentration-dependent damage to HUVECs by H_2_O_2_, with concentrations ranging from 0 to 700μM. The cell survival rate exhibited a negative correlation with the concentration, (correlation coefficient, r = 0.92; half maximal inhibitory concentration, IC_50_ = 623.6μM). After HUVECs were exposed to H_2_O_2_ for 20 h, the cell survival rate decreased by 45%, the apoptosis rate increased by 35%, and there was a 1.2-fold increase in the expression of cleaved caspase-3 protein. Reactive oxygen species (ROS) levels increased by 4.4 times, and lactate dehydrogenase release increased, while the cell migration rate and angiogenesis were inhibited. These results indicate that H_2_O_2_ detrimentally affects the morphology and functionality of HUVECs, confirming the successfully establishment of a damaged model.
Microvesicles represent a vital medium for intercellular communication [20]. Various bioactive substances, including proteins, lipids, carbohydrates, and nucleic acids, attach to the inner surface of the plasma membrane. During microvesicles formation, these substances are encapsulated, entering the intercellular space upon secretion, thereby exerting a biological influence on receptor cells [21]. The composition of bioactive substances released by microvesicles correlates with the microenvironment of the cells generating them [21]. The impact of HSC-MVs on vascular endothelial cell damage was explored in this study. The findings indicate that microvesicles released by hepatic stellate cells exhibit varied effects on H_2_O_2_ induced HUVECs injury under different conditions. MVs derived from unstimulated human LX-2 cells (human hepatic stellate cells) (HSC-MV) demonstrate cytoprotective properties, alleviating cell damage in H_2_O_2_-induced HUVECs injury. Concurrent exposure of HSC-MVs (2×10^8^/mL) and H_2_O_2_ (600μm) to HUVECs culture medium for 20 h resulted in increased cell survival rates, reduced cytotoxicity and apoptosis, improved oxidative stress response, enhanced cell migration ability, and increased angiogenesis. Conversely, microvesicles derived from TGF-β1-stimulated human LX-2 cells (TGF-β1HSC-MVs) exacerbated cell damage in H_2_O_2_-induced HUVECs injury. Simultaneous exposure of TGF-β1HSC-MVs (2×10^8^/mL) and H_2_O_2_ (600 μm) to HUVECs medium led to a further reduction in cell survival rates, increased cytotoxicity and apoptosis, aggravated oxidative stress, inhibited cell migration capacity and decreased angiogenesis.
The phosphatidylinositol 3-kinase (PI3Ks) protein family regulates various cellular functions such as proliferation, differentiation, and apoptosis [22]. AKT, also known as protein kinase B (PKB), is the primary downstream effector of PI3K. Activated AKT modulates cellular functions, such as anti-apoptosis and enhanced cell growth, by phosphorylating downstream factors, including enzymes, kinases, and transcription factors [23]. The MEK/ERK signaling pathway is involved in mediating diverse cellular functions, including proliferation, apoptosis, differentiation, migration and angiogenesis [24].
To determine whether the PI3K/AKT and MEK/ERK signaling pathways were responsible for the effects of HSC-MVs and TGF-β1HSC-MVs, we detected the expression of total proteins and phosphorylated proteins of PI3K, ARK, MEK1/2, and ERK1/2 in H_2_O_2_-induced HUVECs injury using western blot analysis. The results showed that H_2_O_2_ induced the downregulation of phosphorylated PI3K, AKT, MEKI/2, and ERK1/2. Static HSC-MVs mitigated the downregulation of phosphorylated PI3K, AKT, MEK1/2 and ERK1/2 protein expression caused by H_2_O_2_. In contrast, TGF-β1-activated HSC-MVs further exacerbated the downregulation of phosphorylated PI3K, AKT, MEK1/2 and ERK1/2 protein expression. These results affirm that HSC-MVs can activate the PI3K/AKT and MEK/ERK signaling pathways, while TGF-β1-activated HSC-MVs can inhibit the PI3K/AKT and MEK/ERK signaling pathways in H_2_O_2_-induced HUVECs injury.
Our data showed that H_2_O_2_ stimulation led to the downregulation of VEGF, eNOS, and CXCR4 protein expression. HSC-MVs reversed the effects of H_2_O_2_, upregulating VEGF, eNOS and CXCR4 protein expression, while TGF-β1HSC-MVs intensified the impact of H_2_O_2_, further downregulating VEGF, eNOS, and CXCR4 protein expression.
To validate the results of the in vitro experiments, we established an animal model of liver injury using CCl_4_. The results showed an increase in serum ALT and AST, which were 20 and 30 times higher than the control group. Serum ALT and AST are important indicators for detecting whether liver function is normal [25]. Elevated serum ALT and AST levels indicate severe damage to liver function [26]. Histopathological examination of the liver revealed hepatocellular fatty degeneration, inflammatory cell infiltration, fibrous tissue hyperplasia, fibrous septa, and perivascular collagen fiber formation. In addition, the expression of vascular endothelial markers CD31 and CD34 increased. These results indicate liver vascular damage and compensatory proliferation of collagen fibers and the vascular endothelium.
The effects of different states on CCl_4_-induced liver injury and hepatic vascular injuries were investigated in this study. Both intraperitoneal injection of CCl_4_ and tail vein injection of unstimulated HSC-MVs (2×10^8^/mL) significantly improved liver and hepatic vascular injury. This was manifested by reduced serum ALT and AST levels, diminished liver tissue fat formation, decreased inflammatory cell infiltration, thinner collagen fiber bands, and downregulated CD31 and CD34 expression. These findings substantiate that unstimulated HSC-MVs have a protective effect against liver and hepatic vascular injury. However, simultaneous treatment with HSC-MVs (2x10^8^/mL) stimulated by TGF-β1 and CCl_4_ worsened liver injury and hepatic vascular injury. This was evidenced by increased serum ALT and AST levels, aggravated liver tissue adipogenesis, heightened inflammatory cell infiltration, thicker collagen fiber bands, and upregulated CD31 and CD34 expression, underscoring the aggravating effect of TGF-β1-stimulated HSC-MVs on liver injury and hepatic vascular injury. These results align with the in vitro experimental results.
This study used HUVECs and rats to investigate the effects of HSC-MVs on endothelial cells and vascular injury during liver damage. Preliminary findings demonstrated that static HSC-MVs have a protective effect against vascular injury, whereas TGF-β1-activated HSC-MVs exacerbate vascular injury. However, the study did not further analyze or investigate the related mechanisms and signaling pathways in vitro, resulting in some limitations. The protective and damaging effects of HSC-MVs on blood vessels still require further research. HSC-MVs may represent a new therapeutic target for liver injury and liver fibrosis.
Conclusion
MVs produced by unstimulated HSCs (HSC-MVs) exert a protective effect on H_2_O_2_-induced HUVECs injury, whereas those produced by TGF-β1-stimulated HSCs (TGF-β1HSC-MVs) exacerbate H_2_O_2_-induced HUVECs injury. The effects of HSC-MV and TGF-β1HSC-MVs are mediated through the PI3K/AKT/VEGF, CXCR4, and MEK/ERK/eNOS signaling pathways. Simultaneously, HSC-MVs confer a protective effect against CCl_4_-induced liver injury and hepatic vascular injury in rats, while ^TGFβ1^HSC-MVs elicit an aggravating effect on CCl_4_-induced liver injury and hepatic vascular injury in rats.
Supporting information
S1 Graphical abstract(TIF)
S1 Raw images(PDF)
S1 Data(PDF)
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Bajaj JS, Moreau R, Kamath PS, Vargas HE, Arroyo V, Reddy KR, et al. Acute-on-Chronic Liver Failure: Getting Ready for Prime Time? Hepatology. 2018;68(4):1621–32. doi: 10.1002/hep.30056 29689120 · doi ↗ · pubmed ↗
- 2Winkler M, Staniczek T, Kürschner SW, Schmid CD, Schönhaber H, Cordero J, et al. Endothelial GATA 4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling. J Hepatol. 2021;74(2):380–93. doi: 10.1016/j.jhep.2020.08.033 32916216 · doi ↗ · pubmed ↗
- 3Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397–411. doi: 10.1038/nrgastro.2017.38 28487545 · doi ↗ · pubmed ↗
- 4Trinh VQ-H, Lee T-F, Lemoinne S, Ray KC, Ybanez MD, Tsuchida T, et al. Hepatic stellate cells maintain liver homeostasis through paracrine neurotrophin-3 signaling that induces hepatocyte proliferation. Sci Signal. 2023;16(787):eadf 6696. doi: 10.1126/scisignal.adf 6696 37253090 PMC 10367116 · doi ↗ · pubmed ↗
- 5Geervliet E, Bansal R. Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases. Cells. 2020;9(5). doi: 10.3390/cells 9051212 32414178 PMC 7290342 · doi ↗ · pubmed ↗
- 6Wan L, Xia T, Du Y, Liu J, Xie Y, Zhang Y et al. Exosomes from activated hepatic stellate cells contain GLUT 1 and PKM 2: a role for exosomes in metabolic switch of liver nonparenchymal cells. FASEB Journal: Official Publication of the Federation of American Societies For Experimental Biology. 2019;33(7):8530–42. doi: 10.1096/fj.201802675 R 30970216 · doi ↗ · pubmed ↗
- 7Huang R, Pan Q, Ma X, Wang Y, Liang Y, Dai B et al. Hepatic Stellate Cell-Derived Microvesicles Prevent Hepatocytes from Injury Induced by APAP/H 2O 2. Stem Cells Int. 2016;2016:8357567. doi: 10.1155/2016/8357567 27239205 PMC 4864545 · doi ↗ · pubmed ↗
- 8Cocozza F, Grisard E, Martin-Jaular L, Mathieu M, Théry C. Snap Shot: Extracellular Vesicles. Cell. 2020;182(1). doi: 10.1016/j.cell.2020.04.054 32649878 · doi ↗ · pubmed ↗